image
Healthcare - Biotechnology - NASDAQ - US
$ 1.06
-7.02 %
$ 6.79 M
Market Cap
-0.27
P/E
CASH FLOW STATEMENT
-6.81 M OPERATING CASH FLOW
39.15%
1.5 M INVESTING CASH FLOW
0.00%
4.13 M FINANCING CASH FLOW
-54.72%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Adial Pharmaceuticals, Inc.
image
Net Income -7 M
Depreciation & Amortization 564
Capital Expenditures 6.81 M
Stock-Based Compensation 1.75 M
Change in Working Capital -794 K
Others 539 K
Free Cash Flow 0

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
OPERATING CASH FLOW
Net Income (7.0) (12.7) (19.4) (10.9) (8.6) (11.6) (1.1) (0.4) (0.8)
Depreciation & Amortization 564 60.5 K 55.1 K 564 565 563 565 565 565
Deferred Income Tax (1.9) 502 94.1 K (1.6) 0 3.5 0 0 0
Stock Based Compensation 1.7 3.4 4.2 2.0 1.6 5.4 0.2 0.2 0.3
Other Operating Activities 1.1 (0.5) 1.8 1.6 0.4 1.1 0.1 7 1.09 K
Change in Working Capital (0.8) (1.4) 1.5 1.2 0.2 (0.8) 0.3 8.32 K 0.1
Cash From Operations (6.8) (11.2) (11.9) (7.6) (6.3) (2.5) (0.5) (0.3) (0.5)
INVESTING CASH FLOW
Capital Expenditures 6.8 0 64.6 K 0 0 0 0 0 0
Other Items (5.3) 0 30.6 K (0.3) 0 0 35.1 K 0 0
Cash From Investing Activities 1.5 0 34 K (0.3) 0 0 35.1 K 0 0
FINANCING CASH FLOW
Common Stock Repurchased 1.66 K 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0 0 75 K 0.3 0.2 0
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 1.86 K 1.9 0.5 1.1 0.2 0 0 0
Cash From Financing Activities 4.1 9.1 13.6 5.6 9.2 6.3 0.4 0.2 0
CHANGE IN CASH
Net Change In Cash (1.2) (2.1) 1.7 (2.4) 2.9 3.9 69.7 K 74.4 K (0.5)
FREE CASH FLOW
Free Cash Flow 0 (11.2) (12.0) (7.6) (6.3) (2.5) (0.5) (0.3) (0.5)